Article
Exosomes Derived from Hypoxic Glioma Cells Reduce the Sensitivity of Glioma Cells to…
Drug Design, Development and Therapy · 2022 · Wu P, Guo J, Yang H, Yuan D, Wang C, Wang Z
Key facts
| Title | Exosomes Derived from Hypoxic Glioma Cells Reduce the Sensitivity of Glioma Cells to Temozolomide Through Carrying miR-106a-5p |
|---|---|
| First author | Wu P, Guo J, Yang H, Yuan D, Wang C, Wang Z |
| Journal | Drug Design, Development and Therapy |
| Published | Oct 13, 2022 |
| DOI | 10.2147/DDDT.S382690 |
| Devices mentioned | 215006 |
At a glance
- 1–9 FDA submissions mentioned
- None Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1